A Nature Medicine study from Columbia finds stalled production of new neurons in the hippocampus, the brain's memory and emotion hub, in adults with major depression, reframing the condition as a multi system problem of cellular adaptation, not a
Adults with major depressive disorder show stalled production of new neurons in the hippocampus, the brain's memory-and-emotion hub, according to a Nature Medicine study from Columbia University that provides the first direct molecular look at the process in adult human tissue.
The hippocampus is one of the few brain regions that keeps generating neurons throughout life. Those new cells support a function called pattern separation: the everyday ability to tell similar memories apart so an old emotional charge does not bleed into a new situation. When neurogenesis stalls, that discrimination may erode, which could help explain why depression makes past pain feel like present danger.
The Columbia team, led by Maura Dupont, integrated cell-by-cell gene expression, chromatin accessibility, and protein measurements from postmortem hippocampal tissue of nonmedicated adults with depression. They found that the developmental program that turns neural precursors into mature neurons is interrupted, with stress-related and interferon signaling active across stages and excitatory-inhibitory neuron networks dysregulated. The hippocampus is not the only brain region involved, and the study is one paper, not consensus.
The finding sharpens a shift Dupont describes in the institutional release: depression is now seen as a problem of neurons' ability to adapt to stress and changing environments, not a single chemical shortage. Serotonin remains part of the picture. Watch the next wave of biologically stratified treatment research, where molecular targets in the hippocampal neurogenic program, not just neurotransmitter levels, start to drive trial design.